Delaware |
001-39408 |
85-0891392 |
||||||
(State or other jurisdiction of incorporation or organization) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
||||||
7373 Gateway Boulevard
Newark, CA
|
94560 |
|||||||
(Address of Principal Executive Offices) |
(Zip Code) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
||||||||||||
Class A Common Stock, $0.0001 par value per share | LCID | The Nasdaq Stock Market LLC |
Exhibit Number |
Description | |||||||
99.1 | ||||||||
104 | Cover Page Interactive Data File (embedded within the inline XBRL document) |
Dated: November 7, 2024 |
||||||||
Lucid Group, Inc. | ||||||||
By: |
/s/ Gagan Dhingra | |||||||
Gagan Dhingra | ||||||||
Interim Chief Financial Officer |
![]() |
Exhibit 99.1 |
September 30, 2024 |
December 31, 2023 |
|||||||||||||
ASSETS | ||||||||||||||
Current assets: | ||||||||||||||
Cash and cash equivalents | $ | 1,893,638 | $ | 1,369,947 | ||||||||||
Short-term investments (including $15,000 and nil associated with a related party as of September 30, 2024 and December 31, 2023, respectively) | 1,578,283 | 2,489,798 | ||||||||||||
Accounts receivable, net (including $70,846 and $35,526 from a related party as of September 30, 2024 and December 31, 2023, respectively) | 98,243 | 51,822 | ||||||||||||
Inventory | 506,842 | 696,236 | ||||||||||||
Prepaid expenses | 62,210 | 69,682 | ||||||||||||
Other current assets | 107,795 | 79,670 | ||||||||||||
Total current assets | 4,247,011 | 4,757,155 | ||||||||||||
Property, plant and equipment, net | 3,222,098 | 2,810,867 | ||||||||||||
Right-of-use assets | 220,616 | 221,508 | ||||||||||||
Long-term investments | 555,521 | 461,029 | ||||||||||||
Other noncurrent assets | 198,277 | 180,626 | ||||||||||||
Investments in equity securities of a related party | 45,660 | 81,533 | ||||||||||||
TOTAL ASSETS | $ | 8,489,183 | $ | 8,512,718 | ||||||||||
LIABILITIES | ||||||||||||||
Current liabilities: | ||||||||||||||
Accounts payable | $ | 139,187 | $ | 108,724 | ||||||||||
Accrued compensation | 138,882 | 92,494 | ||||||||||||
Finance lease liabilities, current portion | 6,921 | 8,202 | ||||||||||||
Other current liabilities (including $70,495 and $92,258 associated with related parties as of September 30, 2024 and December 31, 2023, respectively) | 861,074 | 798,990 | ||||||||||||
Total current liabilities | 1,146,064 | 1,008,410 | ||||||||||||
Finance lease liabilities, net of current portion | 75,027 | 77,653 | ||||||||||||
Common stock warrant liability | 32,819 | 53,664 | ||||||||||||
Long-term debt | 2,000,847 | 1,996,960 | ||||||||||||
Other long-term liabilities (including $120,286 and $178,311 associated with related parties as of September 30, 2024 and December 31, 2023, respectively) | 558,525 | 524,339 | ||||||||||||
Derivative liabilities associated with redeemable convertible preferred stock (related party) | 932,025 | — | ||||||||||||
Total liabilities | 4,745,307 | 3,661,026 | ||||||||||||
REDEEMABLE CONVERTIBLE PREFERRED STOCK | ||||||||||||||
Preferred stock 10,000,000 shares authorized as of September 30, 2024 and December 31, 2023, Series A redeemable convertible preferred stock, par value $0.0001; 100,000 and 0 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively (related party) | 591,897 | — | ||||||||||||
Preferred stock 10,000,000 shares authorized as of September 30, 2024 and December 31, 2023, Series B redeemable convertible preferred stock, par value $0.0001; 75,000 and 0 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively (related party) | 468,259 | — | ||||||||||||
Total redeemable convertible preferred stock | 1,060,156 | — | ||||||||||||
STOCKHOLDERS’ EQUITY | ||||||||||||||
Common stock, par value $0.0001; 15,000,000,000 shares authorized as of September 30, 2024 and December 31, 2023; 2,338,376,367 and 2,300,111,489 shares issued and 2,337,518,542 and 2,299,253,664 shares outstanding as of September 30, 2024 and December 31, 2023, respectively | 234 | 230 | ||||||||||||
Additional paid-in capital | 15,206,764 | 15,066,080 | ||||||||||||
Treasury stock, at cost, 857,825 shares at September 30, 2024 and December 31, 2023 | (20,716) | (20,716) | ||||||||||||
Accumulated other comprehensive income | 12,914 | 4,850 | ||||||||||||
Accumulated deficit | (12,515,476) | (10,198,752) | ||||||||||||
Total stockholders’ equity | 2,683,720 | 4,851,692 | ||||||||||||
TOTAL LIABILITIES, REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY | $ | 8,489,183 | $ | 8,512,718 |
Three Months Ended September 30, |
Nine Months Ended September 30, |
||||||||||||||||||||||
2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
Revenue (including $45,588 and $4,980 from a related party for the three months ended September 30, 2024 and 2023, and $133,424 and $4,980 for the nine months ended September 30, 2024 and 2023, respectively) | $ | 200,038 | $ | 137,814 | $ | 573,359 | $ | 438,120 | |||||||||||||||
Costs and expenses | |||||||||||||||||||||||
Cost of revenue | 412,544 | 469,722 | 1,287,695 | 1,526,051 | |||||||||||||||||||
Research and development | 324,371 | 230,758 | 896,168 | 694,035 | |||||||||||||||||||
Selling, general and administrative | 233,585 | 189,691 | 657,062 | 556,209 | |||||||||||||||||||
Restructuring charges | 76 | 518 | 20,304 | 24,546 | |||||||||||||||||||
Total cost and expenses | 970,576 | 890,689 | 2,861,229 | 2,800,841 | |||||||||||||||||||
Loss from operations | (770,538) | (752,875) | (2,287,870) | (2,362,721) | |||||||||||||||||||
Other income (expense), net | |||||||||||||||||||||||
Change in fair value of common stock warrant liability | (13,748) | 60,316 | 20,845 | 61,647 | |||||||||||||||||||
Change in fair value of equity securities of a related party | (8,836) | — | (38,159) | — | |||||||||||||||||||
Change in fair value of derivative liabilities associated with redeemable convertible preferred stock (related party) | (240,250) | — | (137,250) | — | |||||||||||||||||||
Interest income | 50,017 | 66,064 | 155,201 | 145,594 | |||||||||||||||||||
Interest expense | (8,478) | (3,340) | (22,652) | (17,138) | |||||||||||||||||||
Other expense, net | (155) | (763) | (6,229) | (1,024) | |||||||||||||||||||
Total other income (expense), net | (221,450) | 122,277 | (28,244) | 189,079 | |||||||||||||||||||
Loss before provision for income taxes | (991,988) | (630,598) | (2,316,114) | (2,173,642) | |||||||||||||||||||
Provision for income taxes | 487 | 296 | 610 | 1,012 | |||||||||||||||||||
Net loss | (992,475) | (630,894) | (2,316,724) | (2,174,654) | |||||||||||||||||||
Accretion of redeemable convertible preferred stock (related party) | 42,838 | — | (107,924) | — | |||||||||||||||||||
Net loss attributable to common stockholders, basic and diluted | $ | (949,637) | $ | (630,894) | $ | (2,424,648) | $ | (2,174,654) | |||||||||||||||
Weighted-average shares outstanding attributable to common stockholders, basic and diluted | 2,323,971,541 | 2,284,446,783 | 2,312,249,333 | 2,010,916,100 | |||||||||||||||||||
Net loss per share attributable to common stockholders, basic and diluted | $ | (0.41) | $ | (0.28) | $ | (1.05) | $ | (1.08) | |||||||||||||||
Other comprehensive income (loss) | |||||||||||||||||||||||
Net unrealized gains on investments, net of tax | $ | 11,891 | $ | 1,554 | $ | 7,672 | $ | 2,590 | |||||||||||||||
Foreign currency translation adjustments | 5,182 | (1,967) | 392 | (1,381) | |||||||||||||||||||
Total other comprehensive income (loss) | 17,073 | (413) | 8,064 | 1,209 | |||||||||||||||||||
Comprehensive loss | (975,402) | (631,307) | (2,308,660) | (2,173,445) | |||||||||||||||||||
Accretion of redeemable convertible preferred stock (related party) | 42,838 | — | (107,924) | — | |||||||||||||||||||
Comprehensive loss attributable to common stockholders | $ | (932,564) | $ | (631,307) | $ | (2,416,584) | $ | (2,173,445) |
Three Months Ended September 30, |
Nine Months Ended September 30, |
||||||||||||||||||||||
2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
Cash flows from operating activities: | |||||||||||||||||||||||
Net loss | $ | (992,475) | $ | (630,894) | $ | (2,316,724) | $ | (2,174,654) | |||||||||||||||
Adjustments to reconcile net loss to net cash used in operating activities: | |||||||||||||||||||||||
Depreciation and amortization | 69,473 | 60,832 | 204,494 | 166,033 | |||||||||||||||||||
Amortization of insurance premium | 8,645 | 9,114 | 25,959 | 30,242 | |||||||||||||||||||
Non-cash operating lease cost | 7,861 | 6,593 | 22,997 | 18,871 | |||||||||||||||||||
Stock-based compensation | 88,094 | 68,237 | 208,803 | 193,432 | |||||||||||||||||||
Inventory and firm purchase commitments write-downs | 138,557 | 230,816 | 416,098 | 734,495 | |||||||||||||||||||
Change in fair value of common stock warrant liability | 13,748 | (60,316) | (20,845) | (61,647) | |||||||||||||||||||
Change in fair value of equity securities of a related party | 8,836 | — | 38,159 | — | |||||||||||||||||||
Change in fair value of derivative liabilities associated with redeemable convertible preferred stock (related party) | 240,250 | — | 137,250 | — | |||||||||||||||||||
Net accretion of investment discounts/premiums | (15,272) | (35,766) | (59,580) | (74,928) | |||||||||||||||||||
Other non-cash items | (178) | 16,480 | 4,766 | 27,938 | |||||||||||||||||||
Changes in operating assets and liabilities: | |||||||||||||||||||||||
Accounts receivable (including $6,962 and $(5,533) from a related party for the three months ended September 30, 2024 and 2023, and $(35,320) and $(5,533) for the nine months ended September 30, 2024 and 2023, respectively) |
3,011 | (2,800) | (46,601) | (3,778) | |||||||||||||||||||
Inventory | (137,982) | (127,971) | (221,392) | (575,933) | |||||||||||||||||||
Prepaid expenses | 782 | (12,027) | (18,487) | (43,062) | |||||||||||||||||||
Other current assets | (5,171) | (4,808) | (27,481) | 13,680 | |||||||||||||||||||
Other noncurrent assets | 8,497 | (4,032) | (14,895) | (113,790) | |||||||||||||||||||
Accounts payable | 39,383 | (18,811) | 42,564 | (114,810) | |||||||||||||||||||
Accrued compensation | 1,508 | (7,460) | 46,388 | (1,781) | |||||||||||||||||||
Other current liabilities | 30,063 | (6,413) | (9,297) | (61,505) | |||||||||||||||||||
Other long-term liabilities | 29,575 | 5,644 | 101,297 | 25,993 | |||||||||||||||||||
Net cash used in operating activities | (462,795) | (513,582) | (1,486,527) | (2,015,204) | |||||||||||||||||||
Cash flows from investing activities: | |||||||||||||||||||||||
Purchases of property, plant and equipment (including $(22,611) and $(25,959) from a related party for the three months ended September 30, 2024 and 2023, and $(56,679) and $(66,877) for the nine months ended September 30, 2024 and 2023, respectively) |
(159,694) | (192,517) | (592,206) | (638,002) | |||||||||||||||||||
Purchases of investments (including $(15,000) and nil from a related party for the three months ended September 30, 2024 and 2023, and $(15,000) and nil for the nine months ended September 30, 2024 and 2023, respectively) |
(520,093) | (1,438,001) | (2,374,220) | (3,585,254) | |||||||||||||||||||
Proceeds from maturities of investments | 963,506 | 498,081 | 3,251,400 | 2,480,570 | |||||||||||||||||||
Proceeds from sale of investments | — | — | 5,000 | 148,388 | |||||||||||||||||||
Other investing activities | — | — | — | (4,827) | |||||||||||||||||||
Net cash provided by (used in) investing activities | $ | 283,719 | $ | (1,132,437) | $ | 289,974 | $ | (1,599,125) | |||||||||||||||
LUCID GROUP, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - CONTINUED
(Unaudited)
(in thousands)
| |||||||||||||||||||||||
Three Months Ended September 30, |
Nine Months Ended September 30, |
||||||||||||||||||||||
2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
Cash flows from financing activities: | |||||||||||||||||||||||
Proceeds from issuance of common stock under Underwriting Agreement, net of issuance costs | $ | — | $ | — | $ | — | $ | 1,184,224 | |||||||||||||||
Proceeds from issuance of common stock under 2023 Subscription Agreement to a related party, net of issuance costs | — | — | — | 1,812,641 | |||||||||||||||||||
Proceeds from issuance of Series A redeemable convertible preferred stock to a related party | — | — | 1,000,000 | — | |||||||||||||||||||
Proceeds from issuance of Series B redeemable convertible preferred stock to a related party | 750,000 | — | 750,000 | — | |||||||||||||||||||
Payments of issuance costs for Series A redeemable convertible preferred stock | — | — | (2,343) | — | |||||||||||||||||||
Payments of issuance costs for Series B redeemable convertible preferred stock | (250) | — | (250) | — | |||||||||||||||||||
Payment for credit facility issuance costs (including $(5,625) and nil to a related party for the three months ended September 30, 2024 and 2023, and $(5,625) and nil for the nine months ended September 30, 2024 and 2023, respectively) |
(6,058) | — | (6,058) | — | |||||||||||||||||||
Payment for finance lease liabilities | (703) | (1,455) | (2,632) | (4,534) | |||||||||||||||||||
Proceeds from borrowings from a related party | — | 38,654 | — | 42,920 | |||||||||||||||||||
Repayment of borrowings from a related party | (21,590) | — | (25,856) | — | |||||||||||||||||||
Proceeds from exercise of stock options | 935 | 2,214 | 3,246 | 7,321 | |||||||||||||||||||
Proceeds from employee stock purchase plan | — | — | 11,104 | 15,089 | |||||||||||||||||||
Tax withholding payments for net settlement of employee awards | (3,190) | (4,327) | (8,502) | (14,705) | |||||||||||||||||||
Net cash provided by financing activities | 719,144 | 35,086 | 1,718,709 | 3,042,956 | |||||||||||||||||||
Net increase (decrease) in cash, cash equivalents, and restricted cash | 540,068 | (1,610,933) | 522,156 | (571,373) | |||||||||||||||||||
Beginning cash, cash equivalents, and restricted cash | 1,353,595 | 2,776,880 | 1,371,507 | 1,737,320 | |||||||||||||||||||
Ending cash, cash equivalents, and restricted cash | $ | 1,893,663 | $ | 1,165,947 | $ | 1,893,663 | $ | 1,165,947 |
Three Months Ended September 30, |
Nine Months Ended September 30, |
||||||||||||||||||||||
2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
Net loss attributable to common stockholders, basic and diluted (GAAP) | $ | (949,637) | $ | (630,894) | $ | (2,424,648) | $ | (2,174,654) | |||||||||||||||
Interest expense | 8,478 | 3,340 | 22,652 | 17,138 | |||||||||||||||||||
Interest income | (50,017) | (66,064) | (155,201) | (145,594) | |||||||||||||||||||
Provision for income taxes | 487 | 296 | 610 | 1,012 | |||||||||||||||||||
Depreciation and amortization | 69,473 | 60,832 | 204,494 | 166,033 | |||||||||||||||||||
Stock-based compensation | 88,094 | 68,237 | 210,283 | 194,875 | |||||||||||||||||||
Restructuring charges | 76 | 518 | 20,304 | 24,546 | |||||||||||||||||||
Change in fair value of common stock warrant liability | 13,748 | (60,316) | (20,845) | (61,647) | |||||||||||||||||||
Change in fair value of equity securities of a related party | 8,836 | — | 38,159 | — | |||||||||||||||||||
Change in fair value of derivative liabilities associated with redeemable convertible preferred stock (related party) | 240,250 | — | 137,250 | — | |||||||||||||||||||
Accretion of redeemable convertible preferred stock (related party) | (42,838) | — | 107,924 | — | |||||||||||||||||||
Adjusted EBITDA (non-GAAP) |
$ | (613,050) | $ | (624,051) | $ | (1,859,018) | $ | (1,978,291) |
Three Months Ended September 30, |
Nine Months Ended September 30, |
||||||||||||||||||||||
2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
Net loss attributable to common stockholders, basic and diluted (GAAP) | $ | (949,637) | $ | (630,894) | $ | (2,424,648) | $ | (2,174,654) | |||||||||||||||
Stock-based compensation | 88,094 | 68,237 | 210,283 | 194,875 | |||||||||||||||||||
Restructuring charges | 76 | 518 | 20,304 | 24,546 | |||||||||||||||||||
Change in fair value of common stock warrant liability | 13,748 | (60,316) | (20,845) | (61,647) | |||||||||||||||||||
Change in fair value of equity securities of a related party | 8,836 | — | 38,159 | — | |||||||||||||||||||
Change in fair value of derivative liabilities associated with redeemable convertible preferred stock (related party) | 240,250 | — | 137,250 | — | |||||||||||||||||||
Accretion of redeemable convertible preferred stock (related party) | (42,838) | — | 107,924 | — | |||||||||||||||||||
Adjusted net loss attributable to common stockholders, basic and diluted (non-GAAP) | $ | (641,471) | $ | (622,455) | $ | (1,931,573) | $ | (2,016,880) |
Three Months Ended September 30, |
Nine Months Ended September 30, |
||||||||||||||||||||||
2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
Net loss per share attributable to common stockholders, basic and diluted (GAAP) | $ | (0.41) | $ | (0.28) | $ | (1.05) | $ | (1.08) | |||||||||||||||
Stock-based compensation | 0.04 | 0.03 | 0.09 | 0.10 | |||||||||||||||||||
Restructuring charges | — | 0.01 | 0.01 | 0.01 | |||||||||||||||||||
Change in fair value of common stock warrant liability | 0.01 | (0.03) | (0.01) | (0.03) | |||||||||||||||||||
Change in fair value of equity securities of a related party | — | — | 0.01 | — | |||||||||||||||||||
Change in fair value of derivative liabilities associated with redeemable convertible preferred stock (related party) | 0.10 | — | 0.06 | — | |||||||||||||||||||
Accretion of redeemable convertible preferred stock (related party) | (0.02) | — | 0.05 | — | |||||||||||||||||||
Adjusted net loss per share attributable to common stockholders, basic and diluted (non-GAAP) | $ | (0.28) | $ | (0.27) | $ | (0.84) | $ | (1.00) | |||||||||||||||
Weighted-average shares outstanding attributable to common stockholders, basic and diluted | 2,323,971,541 | 2,284,446,783 | 2,312,249,333 | 2,010,916,100 |
Three Months Ended September 30, |
Nine Months Ended September 30, |
||||||||||||||||||||||
2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
Net cash used in operating activities (GAAP) | $ | (462,795) | $ | (513,582) | $ | (1,486,527) | $ | (2,015,204) | |||||||||||||||
Capital expenditures | (159,694) | (192,517) | (592,206) | (638,002) | |||||||||||||||||||
Free cash flow (non-GAAP) |
$ | (622,489) | $ | (706,099) | $ | (2,078,733) | $ | (2,653,206) |